Preface |
|
xxiii | |
Acknowledgments |
|
xxvii | |
Authors |
|
xxix | |
|
PART I Biomaterials Science |
|
|
|
Chapter 1 Biomaterials Science and Engineering |
|
|
3 | (24) |
|
|
3 | (1) |
|
1.1 Materials Science and Engineering |
|
|
3 | (1) |
|
1.2 Multilevel of Structure and Categorization of Materials |
|
|
4 | (5) |
|
1.3 Four Categories of Materials |
|
|
9 | (9) |
|
|
9 | (2) |
|
|
11 | (2) |
|
|
13 | (2) |
|
|
15 | (3) |
|
1.4 Definitions of Biomaterials, Biomedical Materials, and Biological Materials |
|
|
18 | (2) |
|
|
20 | (3) |
|
|
23 | (4) |
|
|
23 | (1) |
|
Simple Questions in Class |
|
|
24 | (1) |
|
|
24 | (1) |
|
|
25 | (2) |
|
Chapter 2 Toxicity and Corrosion |
|
|
27 | (36) |
|
|
27 | (1) |
|
|
27 | (2) |
|
2.2 Biological Roles and Toxicities of Trace Elements |
|
|
29 | (1) |
|
2.3 Selection of Metallic Elements in Medical-Grade Alloys |
|
|
30 | (3) |
|
|
33 | (8) |
|
2.4.1 Why Do Metals Corrode? |
|
|
33 | (1) |
|
2.4.2 Corrosion Tendencies of Dissimilar Metals: Electrode Potentials |
|
|
34 | (2) |
|
2.4.3 Factors Affecting Electrode Potentials |
|
|
36 | (1) |
|
|
37 | (1) |
|
2.4.5 Corrosion Possibility of a Metal under Different Conditions: Pourbaix Diagrams |
|
|
38 | (3) |
|
2.5 Environment inside the Body |
|
|
41 | (1) |
|
2.6 Minimization of Toxicity of Metal Implants |
|
|
42 | (1) |
|
|
43 | (20) |
|
|
43 | (1) |
|
Simple Questions in Class |
|
|
43 | (1) |
|
|
44 | (2) |
|
Advanced Topic: Biological Roles of Alloying Elements |
|
|
46 | (8) |
|
|
54 | (9) |
|
Chapter 3 Mechanical Properties of Biomaterials |
|
|
63 | (24) |
|
|
63 | (1) |
|
3.1 Role of Implant Biomaterials |
|
|
63 | (1) |
|
3.2 Mechanical Properties of General Importance |
|
|
64 | (1) |
|
|
65 | (3) |
|
3.4 Elasticity: Resilience and Stretchability |
|
|
68 | (1) |
|
3.5 Mechanical Properties Terms Used in the Medical Community |
|
|
69 | (1) |
|
|
69 | (7) |
|
|
69 | (3) |
|
3.6.2 Stress Corrosion Cracking |
|
|
72 | (4) |
|
3.7 Essential Mechanical Properties of Orthopedic Implant Biomaterials |
|
|
76 | (4) |
|
3.7.1 Mechanical Working Environments of Implants in the Body |
|
|
76 | (1) |
|
|
76 | (1) |
|
3.7.1.2 Fretting Fatigue and Corrosion Fretting Fatigue |
|
|
77 | (1) |
|
|
78 | (2) |
|
|
80 | (1) |
|
|
80 | (7) |
|
|
81 | (1) |
|
Simple Questions in Class |
|
|
82 | (1) |
|
|
82 | (2) |
|
|
84 | (3) |
|
Chapter 4 Metallic Biomaterials in Orthopedic Implants |
|
|
87 | (44) |
|
|
87 | (1) |
|
4.1 Development of Metallic Biomaterials |
|
|
87 | (2) |
|
|
89 | (16) |
|
4.2.1 Corrosion Resistance of Stainless Steels |
|
|
91 | (1) |
|
4.2.1.1 Chromium (Passivity) |
|
|
91 | (1) |
|
4.2.1.2 Nickel (Passivity and FCC Structure Formation) |
|
|
92 | (1) |
|
4.2.1.3 Molybdenum (Carbide Formation and Minimization of Pitting Corrosion) |
|
|
93 | (1) |
|
4.2.1.4 Nitrogen (Enhance Resistance to Pitting and Crevice Corrosion) |
|
|
93 | (1) |
|
4.2.1.5 Metallurgical Processing Routes That Enhance Corrosion Resistance |
|
|
94 | (1) |
|
4.2.1.6 Stress Corrosion Cracking |
|
|
94 | (1) |
|
|
94 | (1) |
|
4.2.2 Biocompatibility of Stainless Steels |
|
|
95 | (1) |
|
4.2.3 Mechanical Properties of Implant-Grade Stainless Steels |
|
|
96 | (1) |
|
4.2.4 Application Principles of Stainless Steels in Orthopedics |
|
|
96 | (3) |
|
4.2.5 Critical-Sized Defects |
|
|
99 | (4) |
|
4.2.6 Current Issues and Challenges |
|
|
103 | (2) |
|
|
105 | (7) |
|
4.3.1 Corrosion Resistance of Cobalt--Chromium Alloys |
|
|
105 | (1) |
|
4.3.2 Biocompatibility of Cobalt Alloys |
|
|
106 | (1) |
|
4.3.3 Mechanical Properties of Medical-Grade Cobalt Alloys |
|
|
107 | (2) |
|
4.3.4 Medical Applications of Cobalt Alloys |
|
|
109 | (1) |
|
4.3.5 Current Issues and Challenges |
|
|
110 | (1) |
|
|
111 | (1) |
|
|
112 | (9) |
|
4.4.1 Corrosion Resistance of Titanium and Its Alloys |
|
|
112 | (1) |
|
4.4.2 Biocompatibility of Titanium Alloys |
|
|
113 | (1) |
|
4.4.3 Bone-Bonding Ability of Ti and Ti Alloys |
|
|
113 | (1) |
|
4.4.4 Mechanical Properties of Titanium Alloys |
|
|
114 | (1) |
|
4.4.4.1 Commercial Pure Titanium |
|
|
114 | (2) |
|
4.4.4.2 α--β Titanium Alloys |
|
|
116 | (1) |
|
4.4.4.3 β Titanium Alloys |
|
|
116 | (2) |
|
|
118 | (1) |
|
4.4.6 Clinical Applications of Titanium Alloys |
|
|
119 | (1) |
|
4.4.7 Current Issues and Challenges |
|
|
120 | (1) |
|
4.4.8 Summary of Titanium Alloys |
|
|
121 | (1) |
|
4.5 Comparison of Stainless Steels, Cobalt, and Titanium Alloys |
|
|
121 | (3) |
|
|
124 | (1) |
|
|
124 | (7) |
|
|
125 | (1) |
|
Simple Questions in Class |
|
|
125 | (1) |
|
|
126 | (2) |
|
|
128 | (3) |
|
Chapter 5 Metallic Biomaterials: Miscellaneous Others |
|
|
131 | (31) |
|
|
131 | (1) |
|
|
131 | (9) |
|
5.1.1 HgAgSn Amalgam as Tooth Fillings |
|
|
135 | (1) |
|
5.1.1.1 Corrosion Resistance of Amalgam |
|
|
135 | (1) |
|
5.1.1.2 Special Requirements of Tooth Fillings |
|
|
136 | (1) |
|
5.1.1.3 Properties of HgAgSn Amalgam |
|
|
136 | (1) |
|
|
137 | (1) |
|
5.1.2.1 Corrosion Resistance |
|
|
137 | (1) |
|
5.1.2.2 Alloying Composition and Properties |
|
|
137 | (1) |
|
5.1.2.3 Dental Applications of Noble Alloys |
|
|
137 | (3) |
|
5.2 NiTi Shape-Memory Alloys |
|
|
140 | (11) |
|
5.2.1 Mechanism of the Shape-Memory Effect |
|
|
140 | (2) |
|
5.2.1.1 One-Way Shape-Memory Effect |
|
|
142 | (2) |
|
5.2.1.2 Two-Way Shape-Memory Effect |
|
|
144 | (1) |
|
5.2.2 Corrosion of NiTi Alloys |
|
|
144 | (1) |
|
5.2.3 Biocompatibility of NiTi Alloys |
|
|
144 | (1) |
|
5.2.3.1 In Vitro Evaluation |
|
|
144 | (1) |
|
5.2.3.2 In Vivo Evaluation in Animals |
|
|
144 | (1) |
|
5.2.3.3 In Vivo Trials of NiTi Implants in Humans |
|
|
145 | (1) |
|
5.2.3.4 Biocompatibility of NiTi Wires as Stents (Filters) |
|
|
145 | (1) |
|
5.2.4 Mechanical Properties of NiTi Alloys |
|
|
145 | (1) |
|
5.2.4.1 General Mechanical Properties |
|
|
145 | (1) |
|
5.2.4.2 Fatigue Properties of NiTi Alloys |
|
|
146 | (1) |
|
5.2.5 Medical Applications of NiTi Alloys |
|
|
146 | (1) |
|
5.2.5.1 Cardiovascular Applications of Self-Expandable Stents |
|
|
146 | (1) |
|
5.2.5.2 Gastrointestinal Applications of Self-Expandable Stents |
|
|
147 | (1) |
|
5.2.5.3 Urological and Other Applications of Self-Expandable Stents |
|
|
148 | (1) |
|
5.2.5.4 Orthopedic and Orthodontic Applications of NiTi Implants |
|
|
148 | (2) |
|
5.2.6 Issues and Challenges of NiTi Implants |
|
|
150 | (1) |
|
|
150 | (1) |
|
5.3 Other Clinically Applied Metallic Materials |
|
|
151 | (3) |
|
|
151 | (1) |
|
5.3.1.1 Corrosion and Biocompatibility of Tantalum |
|
|
151 | (1) |
|
5.3.1.2 Clinical Applications of Tantalum |
|
|
151 | (1) |
|
|
151 | (1) |
|
5.3.2.1 Corrosion and Biocompatibility of Zirconium |
|
|
151 | (2) |
|
5.3.2.2 Clinical Application of Zirconium Alloy |
|
|
153 | (1) |
|
|
153 | (1) |
|
5.3.3.1 Biocompatibility of Silver |
|
|
153 | (1) |
|
5.3.3.2 Medical Application of Ag |
|
|
153 | (1) |
|
5.3.4 Metals Used as Medical Electrodes |
|
|
154 | (1) |
|
5.4 New Metallic Materials: Magnesium Alloys |
|
|
154 | (7) |
|
5.4.1 Three Generations of Biomaterials in Terms of Degradability |
|
|
154 | (1) |
|
5.4.2 Rationale of Developing Mg Alloys as Medical Implants |
|
|
155 | (1) |
|
5.4.3 Corrosion of Mg Alloys |
|
|
155 | (2) |
|
5.4.4 Biocompatibility/Toxicity of Mg Alloys |
|
|
157 | (2) |
|
5.4.5 Mechanical Properties of Mg Alloys |
|
|
159 | (1) |
|
5.4.5.1 Mg--Zn-Based Alloys |
|
|
160 | (1) |
|
5.4.5.2 Mg--Ca-Based Alloys |
|
|
160 | (1) |
|
5.4.6 Potential Applications of Magnesium Alloys and Challenges |
|
|
160 | (1) |
|
|
160 | (1) |
|
|
161 | (1) |
|
|
161 | (1) |
|
5.A Appendix Data on Corrosion Resistance and Biocompatibility of Niti Alloys |
|
|
162 | (23) |
|
Simple Questions in Class |
|
|
175 | (1) |
|
|
176 | (3) |
|
|
179 | (6) |
|
Chapter 6 Bioinert Ceramics |
|
|
185 | (28) |
|
|
185 | (1) |
|
6.1 Overview of Bioceramics |
|
|
185 | (3) |
|
6.1.1 Classification of Bioceramics |
|
|
185 | (1) |
|
6.1.2 Three Generations of Bioceramics |
|
|
186 | (1) |
|
6.1.3 Mechanical Sensitivity of Ceramics to Stress Concentration |
|
|
187 | (1) |
|
6.2 Inert Bioceramics: Al2O3 |
|
|
188 | (5) |
|
6.2.1 Corrosion Resistance and Biocompatibility |
|
|
188 | (1) |
|
6.2.2 Mechanical Properties |
|
|
188 | (1) |
|
6.2.3 Medical Applications of Al2O3 |
|
|
189 | (2) |
|
6.2.4 Strategies to Minimize the Wear of Bearing Surfaces |
|
|
191 | (2) |
|
6.2.5 Other Applications of Al2O3 as an Implant Material |
|
|
193 | (1) |
|
6.3 Inert Bioceramics: ZrO2 |
|
|
193 | (1) |
|
|
194 | (1) |
|
6.5 Summary and Remarks on Al2O3 and ZrO2 |
|
|
195 | (1) |
|
|
196 | (3) |
|
6.6.1 Dental Implant Ceramics |
|
|
196 | (1) |
|
|
197 | (2) |
|
|
199 | (14) |
|
|
199 | (1) |
|
Simple Questions in Class |
|
|
200 | (1) |
|
|
201 | (1) |
|
Advanced Topic: Total Joint Replacement |
|
|
202 | (7) |
|
|
209 | (4) |
|
Chapter 7 Bioactive and Bioresorbable Ceramics |
|
|
213 | (44) |
|
|
213 | (1) |
|
7.1 Overview of Surface Bioactive and Bulk Degradable Ceramics |
|
|
213 | (1) |
|
7.2 Calcium Phosphates and Hydroxyapatite |
|
|
214 | (4) |
|
|
214 | (1) |
|
|
214 | (1) |
|
7.2.3 Bone Minerals (Biological Apatite) |
|
|
214 | (1) |
|
7.2.4 Biocompatibility of Synthetic Calcium Phosphates and Hydroxyapatite |
|
|
215 | (1) |
|
7.2.5 Stability of Synthetic Calcium Phosphates and Hydroxyapatites in Physiological Solutions |
|
|
216 | (1) |
|
7.2.6 Mechanical Properties of Synthetic Calcium Phosphates and Hydroxyapatite |
|
|
217 | (1) |
|
7.2.7 Applications of Synthetic Calcium Phosphates and Hydroxyapatites as Implant Materials |
|
|
217 | (1) |
|
|
218 | (4) |
|
7.3.1 Bioactive Silicate Glasses |
|
|
218 | (1) |
|
7.3.1.1 Composition and Biodegradability of Bioactive Silicate Glasses |
|
|
218 | (2) |
|
7.3.1.2 Biocompatibility of Bioactive Silicate Glasses |
|
|
220 | (1) |
|
7.3.1.3 Mechanical Properties |
|
|
220 | (1) |
|
7.3.1.4 Medical Applications of Bioactive Glasses |
|
|
221 | (1) |
|
7.4 Bioactive Glass-Ceramics |
|
|
222 | (1) |
|
|
222 | (1) |
|
7.4.2 Ceravital® Glass-Ceramics |
|
|
223 | (1) |
|
7.4.3 Bioverit® Glass-Ceramics |
|
|
223 | (1) |
|
7.5 Bone-Bonding Mechanisms |
|
|
223 | (6) |
|
7.6 Biodegradable Ceramics |
|
|
229 | (3) |
|
7.6.1 Biodegradation Mechanisms of Amorphous Structures |
|
|
230 | (1) |
|
7.6.2 Biodegradation Mechanisms of Crystalline Structures |
|
|
230 | (1) |
|
7.6.3 Design of Degradation Kinetics of Degradable Biomaterials |
|
|
230 | (2) |
|
7.6.4 How to Tune Bioactivity and Degradation Kinetics of Bioceramics |
|
|
232 | (1) |
|
|
232 | (25) |
|
|
234 | (1) |
|
Simple Questions in Class |
|
|
234 | (1) |
|
|
235 | (1) |
|
Advanced Topic: Bioceramic Scaffolds for Bone Tissue Engineering |
|
|
236 | (15) |
|
|
251 | (6) |
|
Chapter 8 Polymeric Biomaterials: Fundamentals |
|
|
257 | (38) |
|
|
257 | (1) |
|
8.1 Basic Concepts on Polymers |
|
|
257 | (18) |
|
|
258 | (3) |
|
8.1.2 Simplified Illustration of Molecular Structures of Polymers |
|
|
261 | (1) |
|
8.1.3 Why Many Polymers Are Flexible? |
|
|
261 | (2) |
|
8.1.4 Classification of Homo- and Copolymers |
|
|
263 | (1) |
|
8.1.5 Classification of Skeletal Structures |
|
|
264 | (1) |
|
8.1.5.1 Linear or Branched Chain Structures: Thermoplastic Polymers |
|
|
265 | (1) |
|
8.1.5.2 Cross-Linked (Elastomeric) or Networked (Rigid) Structures: Thermoset Polymers |
|
|
265 | (1) |
|
8.1.6 Phase Separation of Polymers |
|
|
266 | (1) |
|
8.1.6.1 Crystallinity of Polymers |
|
|
266 | (1) |
|
8.1.6.2 Segmented Copolymers |
|
|
266 | (1) |
|
8.1.7 Molar Mass (Molecular Weight) of Polymers |
|
|
267 | (1) |
|
8.1.8 Mechanical Properties of Polymers |
|
|
267 | (1) |
|
|
267 | (2) |
|
8.1.8.2 Thermoset Elastomers |
|
|
269 | (1) |
|
8.1.8.3 Thermoplastic Rubbers |
|
|
270 | (1) |
|
|
270 | (2) |
|
8.1.9 Strategies to Strengthen/Harden Polymers |
|
|
272 | (1) |
|
8.1.10 Synthesis of Polymers |
|
|
272 | (2) |
|
8.1.11 Hydrolysis and Chemical Design Principles of Medical Polymers |
|
|
274 | (1) |
|
8.2 Overview of Polymeric Biomaterials |
|
|
275 | (1) |
|
|
275 | (1) |
|
8.2.2 How to Adjust Degradability of Polymers |
|
|
275 | (1) |
|
|
276 | (19) |
|
|
277 | (1) |
|
Simple Questions in Class |
|
|
277 | (2) |
|
|
279 | (1) |
|
Advanced Topic: Polymers and Polymer Scaffolds for Soft Tissue Engineering |
|
|
280 | (10) |
|
|
290 | (5) |
|
Chapter 9 Bioinert Polymers |
|
|
295 | (44) |
|
|
295 | (1) |
|
|
295 | (4) |
|
|
295 | (1) |
|
|
296 | (3) |
|
9.2 Poly(Ethylene Terephthalate) |
|
|
299 | (1) |
|
|
300 | (3) |
|
9.4 Fluorocarbon Polymers |
|
|
303 | (3) |
|
|
306 | (2) |
|
|
308 | (4) |
|
9.6.1 Polymer Chemistry of Polyurethanes |
|
|
308 | (1) |
|
9.6.2 Third Component in PU Synthesis: The Chain Extender |
|
|
309 | (2) |
|
9.6.3 Properties and Medicinal Applications of PUs |
|
|
311 | (1) |
|
|
312 | (27) |
|
|
313 | (1) |
|
Simple Questions in Class |
|
|
313 | (1) |
|
|
314 | (1) |
|
Advanced Topic: Properties and Applications of Polyurethane as Biomaterials |
|
|
315 | (17) |
|
|
332 | (7) |
|
Chapter 10 Bioresorbable Polymers |
|
|
339 | (46) |
|
|
339 | (1) |
|
10.1 Biodegradation of Polymers |
|
|
339 | (4) |
|
10.1.1 Degradation of Polymers |
|
|
339 | (1) |
|
10.1.2 General Process of Polymer Biodegradation |
|
|
340 | (1) |
|
10.1.3 Cleavage of Polymer Chains |
|
|
341 | (1) |
|
10.1.3.1 Hydrolyzable Polymers |
|
|
341 | (2) |
|
10.2 Polyesters: PGA, PLA, and PCL |
|
|
343 | (4) |
|
|
343 | (1) |
|
10.2.2 Synthesis of PGA, PLA, and PCL |
|
|
344 | (1) |
|
10.2.3 Properties of PGA, PLA, and PCL |
|
|
345 | (1) |
|
10.2.4 Degradation of Polyesters |
|
|
345 | (2) |
|
10.2.5 Biocompatibility of Polyesters |
|
|
347 | (1) |
|
10.2.6 Biomedical Applications of PGA, PLA, and PCL |
|
|
347 | (1) |
|
|
347 | (3) |
|
|
347 | (1) |
|
10.3.2 Biocompatibility of PHAs |
|
|
347 | (2) |
|
10.3.3 Biodegradation Rates |
|
|
349 | (1) |
|
10.3.4 Properties of PHAs |
|
|
349 | (1) |
|
10.3.5 Medical Applications of PHAs |
|
|
349 | (1) |
|
10.4 Elastomeric Polyester: Poly(Polyol Sebacate) |
|
|
350 | (4) |
|
10.4.1 Synthesis of Poly(Polyol Sebacate) |
|
|
350 | (1) |
|
10.4.2 Biodegradation and Biocompatibility of PPS |
|
|
351 | (1) |
|
10.4.3 Mechanical Properties of PPS Polymers |
|
|
351 | (1) |
|
10.4.4 Stress--Strain Curves of Synthetic and Biological Elastomers |
|
|
352 | (2) |
|
10.5 Polyether: Poly(Ethylene Glycol) |
|
|
354 | (1) |
|
|
354 | (1) |
|
10.5.2 Applications of PEG |
|
|
354 | (1) |
|
|
354 | (1) |
|
10.6.1 Synthesis of Polyamides |
|
|
354 | (1) |
|
10.6.2 Stability of Peptide Bonds in Aqueous Solution at pH 7 |
|
|
355 | (1) |
|
10.7 Surface-Erodible Polymers |
|
|
355 | (1) |
|
|
356 | (1) |
|
|
356 | (29) |
|
Simple Questions in Class |
|
|
357 | (1) |
|
|
358 | (1) |
|
|
359 | (1) |
|
Advanced Topic: Natural Polymers: Resilin, Silk, and Gluten |
|
|
360 | (18) |
|
|
378 | (7) |
|
Chapter 11 Composite Biomaterials |
|
|
385 | (26) |
|
|
385 | (1) |
|
11.1 Overview of Composites |
|
|
385 | (6) |
|
11.1.1 Definition of Composites |
|
|
386 | (1) |
|
11.1.2 Classification of Composites |
|
|
387 | (1) |
|
11.1.3 General Structure--Property Relationship |
|
|
388 | (1) |
|
11.1.3.1 Effects of Shape |
|
|
388 | (1) |
|
11.1.3.2 Volume Fraction of a Composite |
|
|
388 | (2) |
|
11.1.3.3 Effect of Volume Fraction: The Concept of Load Transfer |
|
|
390 | (1) |
|
11.1.3.4 Prediction of Elastic Properties of Composites |
|
|
390 | (1) |
|
11.1.3.5 Interface Bonding |
|
|
391 | (1) |
|
11.2 Natural Composites: Bone |
|
|
391 | (4) |
|
11.2.1 Constituents of Bone, Dentin, and Enamel (Human) |
|
|
392 | (1) |
|
11.2.1.1 Inorganic Constituents of Bone |
|
|
392 | (1) |
|
11.2.1.2 Organic Constituents of Bone |
|
|
393 | (1) |
|
11.2.1.3 Constituents of Dentine and Enamel |
|
|
393 | (1) |
|
11.2.2 Volume Fraction of Apatite in Bone, Dentin, and Enamel |
|
|
393 | (1) |
|
11.2.3 Prediction of Stiffness of Bone, Dentin, and Enamel |
|
|
393 | (2) |
|
|
395 | (2) |
|
11.3.1 Management of Shrinkage |
|
|
395 | (1) |
|
11.3.2 Glass--Ionomer Cement |
|
|
396 | (1) |
|
|
397 | (1) |
|
|
398 | (13) |
|
|
399 | (1) |
|
Simple Questions in Class |
|
|
399 | (1) |
|
|
400 | (1) |
|
Advanced Topic: Development of Artificial Bone: Composites and Scaffolds |
|
|
401 | (4) |
|
|
405 | (6) |
|
|
|
Chapter 12 Medicine and Medical Science |
|
|
411 | (14) |
|
|
411 | (1) |
|
12.1 Medicine and Medical Science |
|
|
411 | (1) |
|
12.2 Medical Science versus Materials Science |
|
|
412 | (4) |
|
12.3 Learning Goals of Part II |
|
|
416 | (1) |
|
|
417 | (8) |
|
|
418 | (1) |
|
|
418 | (2) |
|
|
420 | (3) |
|
Simple Questions in Class |
|
|
423 | (1) |
|
|
423 | (2) |
|
Chapter 13 Human Anatomy and Diseases I: Integumentary, Skeletal, Muscular, Nervous, and Endocrine Systems |
|
|
425 | (34) |
|
|
425 | (1) |
|
13.1 Integumentary System |
|
|
425 | (4) |
|
13.1.1 Gross Anatomy of Skin |
|
|
425 | (1) |
|
|
426 | (1) |
|
13.1.3 Regenerative Ability of the Skin and Stem Cells |
|
|
427 | (1) |
|
13.1.4 Threatening Skin Injury: Burns |
|
|
427 | (2) |
|
13.1.5 Applications of Biomaterials in Full-Thickness Burns |
|
|
429 | (1) |
|
|
429 | (7) |
|
13.2.1 Gross Anatomy of Skeleton |
|
|
429 | (1) |
|
13.2.1.1 Two Subskeletons |
|
|
429 | (1) |
|
|
430 | (1) |
|
13.2.1.3 Gross Structure of an Individual Long Bone |
|
|
430 | (1) |
|
13.2.1.4 Articulations and Articular Cartilage |
|
|
431 | (1) |
|
|
431 | (1) |
|
13.2.3 Development of Bone |
|
|
432 | (1) |
|
13.2.4 Regenerative Capacity of Bone |
|
|
432 | (3) |
|
13.2.5 The Most Common Bone Disease: Osteoporosis |
|
|
435 | (1) |
|
13.2.6 Applications of Biomaterials in Skeleton System |
|
|
436 | (1) |
|
|
436 | (4) |
|
13.3.1 Gross Anatomy of Muscle |
|
|
436 | (1) |
|
|
437 | (1) |
|
|
438 | (1) |
|
13.3.4 Smooth (Visceral) Muscle |
|
|
438 | (2) |
|
13.3.5 Regenerative Ability and Cancer Susceptibility |
|
|
440 | (1) |
|
|
440 | (7) |
|
13.4.1 Gross Anatomy of the Nervous System |
|
|
440 | (3) |
|
13.4.2 Regenerative Capacity of the PNS and CNS |
|
|
443 | (2) |
|
13.4.3 Nerve Disorders: Degeneration of Brain |
|
|
445 | (1) |
|
13.4.4 Surgical Reconnection of PNS |
|
|
445 | (1) |
|
13.4.5 Application of Biomaterials and Challenges to Nerve Damage |
|
|
445 | (1) |
|
13.4.5.1 Nerve-Bridging Device |
|
|
445 | (1) |
|
13.4.5.2 Nonbiodegradable Artificial Nerve Grafts |
|
|
446 | (1) |
|
13.4.5.3 Neural Tissue Engineering: To Address Major PN Injuries |
|
|
446 | (1) |
|
13.4.5.4 Biomaterials for Drug or Cell Delivery |
|
|
446 | (1) |
|
|
447 | (2) |
|
13.5.1 Gross Anatomy of the Endocrine System |
|
|
447 | (2) |
|
13.5.2 Functions of the Endocrine System |
|
|
449 | (1) |
|
13.5.3 Cellular/Molecular Therapies and Application of Biomaterials |
|
|
449 | (1) |
|
|
449 | (10) |
|
|
450 | (1) |
|
Simple Questions in Class |
|
|
450 | (4) |
|
|
454 | (1) |
|
Advanced Topic: Biomaterial Challenges in Bone Tissue Engineering |
|
|
454 | (2) |
|
|
456 | (3) |
|
Chapter 14 Human Anatomy and Diseases II: Cardiovascular System |
|
|
459 | (30) |
|
|
459 | (1) |
|
14.1 Anatomy and Functions of the Cardiovascular System |
|
|
459 | (8) |
|
|
460 | (1) |
|
|
461 | (1) |
|
|
462 | (1) |
|
|
462 | (1) |
|
14.1.4.1 Arteries, Veins, and Capillaries |
|
|
462 | (3) |
|
14.1.4.2 Aorta and Coronary Arteries of the Heart |
|
|
465 | (2) |
|
14.2 Cardiovascular Disease |
|
|
467 | (5) |
|
14.2.1 Coronary Artery Disease |
|
|
468 | (1) |
|
14.2.2 Brain Vessel Diseases |
|
|
469 | (1) |
|
14.2.3 Hypertensive Heart Disease |
|
|
469 | (1) |
|
|
469 | (2) |
|
14.2.5 Acute Rheumatic Fever and Rheumatic Heart Disease |
|
|
471 | (1) |
|
14.2.6 Peripheral Vascular Disease |
|
|
471 | (1) |
|
14.2.7 Congenital Heart Disease |
|
|
471 | (1) |
|
14.3 Cardiac Performance: P--V Loop |
|
|
472 | (1) |
|
14.4 Current Therapies for Heart Disease |
|
|
472 | (3) |
|
14.5 Alternative Treatments and Application of Biomaterials |
|
|
475 | (7) |
|
|
475 | (1) |
|
14.5.2 Ventricular Restraint |
|
|
476 | (2) |
|
|
478 | (1) |
|
14.5.4 Combinatorial Approach: The Heart Patch |
|
|
479 | (3) |
|
14.6 Artificial Blood Vessels |
|
|
482 | (1) |
|
|
482 | (7) |
|
|
482 | (1) |
|
Simple Questions in Class |
|
|
483 | (2) |
|
|
485 | (1) |
|
|
486 | (3) |
|
Chapter 15 Human Anatomy and Diseases III: Respiratory, Lymphatic, Digestive, Urinary, and Reproductive Systems |
|
|
489 | (30) |
|
|
489 | (1) |
|
|
489 | (7) |
|
15.1.1 Breathing and Respiration |
|
|
489 | (1) |
|
15.1.2 Gross Anatomy and Functions of the Respiratory System |
|
|
490 | (1) |
|
15.1.2.1 Nose, Pharynx, and Larynx (Upper Respiratory Tract) |
|
|
491 | (1) |
|
15.1.2.2 Trachea and Bronchi (Lower Respiratory Tract) |
|
|
491 | (1) |
|
15.1.3 Gross Structure and Functions of the Lungs |
|
|
491 | (2) |
|
15.1.4 Pneumocytes in Alveoli and the Regenerative Ability of Lungs |
|
|
493 | (1) |
|
15.1.5 Lung Disease: Emphysema |
|
|
494 | (1) |
|
15.1.6 New Strategy: Lung Volume Reduction Surgery |
|
|
494 | (1) |
|
15.1.7 Application of Biomaterials: Sealants and Bioartificial Trachea |
|
|
494 | (2) |
|
|
496 | (3) |
|
15.2.1 Gross Anatomy of the Lymphatic System |
|
|
496 | (1) |
|
15.2.1.1 Lymphatic Organs (the Lymphoid System) |
|
|
496 | (2) |
|
15.2.2 Diseases of Lymphatic System |
|
|
498 | (1) |
|
15.2.3 Application of Biomaterials |
|
|
498 | (1) |
|
|
499 | (7) |
|
15.3.1 Gross Anatomy of the Digestive System |
|
|
499 | (1) |
|
15.3.2 Digestion: General Biochemistry of Food Breakdown |
|
|
500 | (1) |
|
15.3.3 Functions of Organs of the Digestive System |
|
|
501 | (1) |
|
|
501 | (1) |
|
15.3.3.2 Pharynx and Esophagus |
|
|
501 | (1) |
|
|
501 | (1) |
|
|
502 | (1) |
|
15.3.3.5 Small Intestine--Associated Glands: Liver and the Pancreas |
|
|
502 | (1) |
|
|
502 | (1) |
|
15.3.3.7 Rectum, Anal Canal, and Anus |
|
|
503 | (1) |
|
15.3.4 Regenerative Ability of Organs of the Digestive System |
|
|
503 | (1) |
|
15.3.5 Digestive System Diseases |
|
|
503 | (1) |
|
15.3.5.1 Cancer and Short Gut Syndrome |
|
|
503 | (1) |
|
15.3.5.2 Progression of Liver Inflammation (Hepatitis) |
|
|
504 | (1) |
|
15.3.6 Application of Biomaterials |
|
|
504 | (1) |
|
15.3.6.1 Intestinal Substitutes |
|
|
504 | (1) |
|
15.3.6.2 Artificial Esophagus |
|
|
504 | (2) |
|
15.3.6.3 Liver Tissue Engineering |
|
|
506 | (1) |
|
|
506 | (5) |
|
15.4.1 Gross Anatomy of the Urinary System |
|
|
506 | (2) |
|
|
508 | (1) |
|
15.4.3 Regeneration of Kidney (Living with One Kidney) |
|
|
509 | (1) |
|
15.4.4 Kidney Failure and Diabetes |
|
|
509 | (2) |
|
15.4.5 Application of Biomaterials |
|
|
511 | (1) |
|
|
511 | (3) |
|
15.5.1 Gross Anatomy of the Human Reproductive System |
|
|
511 | (1) |
|
15.5.1.1 Fertilization and Embryo Formation |
|
|
512 | (1) |
|
15.5.2 Diseases of the Reproductive System |
|
|
513 | (1) |
|
15.5.2.1 Infections of the Reproductive System |
|
|
513 | (1) |
|
15.5.2.2 Congenital Abnormalities |
|
|
513 | (1) |
|
|
513 | (1) |
|
15.5.3 Applications of Biomaterials |
|
|
514 | (1) |
|
|
514 | (5) |
|
|
514 | (1) |
|
Simple Questions in Class |
|
|
515 | (1) |
|
|
515 | (1) |
|
|
516 | (3) |
|
Chapter 16 Cells and Biomolecules |
|
|
519 | (48) |
|
|
519 | (1) |
|
|
519 | (1) |
|
16.2 Cell Biochemistry and Biosynthesis |
|
|
520 | (9) |
|
16.2.1 Chemical Components of a Cell: Biomacromolecules |
|
|
520 | (1) |
|
16.2.1.1 Polysaccharides (Sugar and Starch) |
|
|
520 | (2) |
|
16.2.1.2 Lipids (Fats and Oily Substances) |
|
|
522 | (1) |
|
|
522 | (3) |
|
|
525 | (1) |
|
16.2.2 Types of Biomolecular Bonding |
|
|
525 | (1) |
|
16.2.3 Biosynthesis and Metabolism: The Energy Balance of Cells |
|
|
526 | (1) |
|
|
526 | (1) |
|
16.2.3.2 Why Is a Constant Input of Energy Needed to Sustain Living Organisms? |
|
|
526 | (1) |
|
16.2.3.3 How Do Cells Obtain Energy? |
|
|
527 | (1) |
|
16.2.3.4 How Do Enzymes Find Their Substrates? |
|
|
527 | (1) |
|
16.2.3.5 How Do Cells Obtain Energy from Food? |
|
|
528 | (1) |
|
|
529 | (4) |
|
16.3.1 Structure of Cell Membrane |
|
|
529 | (1) |
|
16.3.1.1 Phospholipid Bilayer |
|
|
529 | (1) |
|
|
529 | (1) |
|
16.3.2 Nucleus, Cytoplasm, and Cytoskeleton |
|
|
529 | (2) |
|
|
531 | (2) |
|
|
533 | (1) |
|
|
533 | (1) |
|
16.4 Transport across Plasma Membranes |
|
|
533 | (3) |
|
|
534 | (1) |
|
16.4.2 Facilitated Diffusion |
|
|
534 | (1) |
|
16.4.3 Active Transport (against a Gradient) |
|
|
535 | (1) |
|
16.4.4 Bulk Transport across Plasma Membranes |
|
|
535 | (1) |
|
16.4.4.1 Pinocytosis and Receptor-Mediated Endocytosis |
|
|
535 | (1) |
|
|
536 | (1) |
|
16.4.4.3 Phagocytes: Cells of the Cellular Defense System |
|
|
536 | (1) |
|
|
536 | (5) |
|
|
537 | (1) |
|
16.5.2 Mitosis and the Cell Cycle |
|
|
538 | (1) |
|
16.5.3 Regeneration versus Cancer |
|
|
538 | (1) |
|
|
539 | (1) |
|
16.5.5 Cell Aging (Senescence) |
|
|
539 | (1) |
|
16.5.6 Phenotype of Proliferating Cells |
|
|
540 | (1) |
|
|
540 | (1) |
|
16.6 Cell Differentiation and Stem Cells |
|
|
541 | (4) |
|
16.6.1 Common Characteristics of Stem Cells |
|
|
542 | (1) |
|
16.6.2 Embryonic Stem Cells |
|
|
542 | (1) |
|
16.6.3 Potency of Stem Cells |
|
|
542 | (1) |
|
16.6.4 Adult (Somatic) Stem Cells |
|
|
543 | (2) |
|
|
545 | (22) |
|
|
546 | (1) |
|
Advanced Topic: Cell Therapy to Treat Cardiac Disease |
|
|
546 | (11) |
|
Simple Questions in Class |
|
|
557 | (2) |
|
|
559 | (1) |
|
|
559 | (8) |
|
Chapter 17 Histology and Tissue Properties I: Epithelial, Neuronal, and Muscle Tissue |
|
|
567 | (42) |
|
|
567 | (1) |
|
|
567 | (2) |
|
17.1.1 Four Types of Tissues |
|
|
568 | (1) |
|
17.1.2 Tissue Composition and Basic Structure |
|
|
569 | (1) |
|
17.1.3 Regeneration and Carcinogenic Susceptibility of Tissues |
|
|
569 | (1) |
|
|
569 | (5) |
|
|
569 | (1) |
|
17.2.2 Examples of Epithelia |
|
|
570 | (1) |
|
|
571 | (2) |
|
17.2.3.1 Endothelium and Vascular Tissue Engineering |
|
|
573 | (1) |
|
|
574 | (9) |
|
17.3.1 Microanatomy of Muscle |
|
|
574 | (1) |
|
|
574 | (1) |
|
17.3.1.2 Cardiac Muscle (Also Called Myocardium) |
|
|
574 | (1) |
|
|
575 | (1) |
|
17.3.2 Proteins in Muscle Cells and Muscle Contraction |
|
|
575 | (1) |
|
|
575 | (2) |
|
17.3.2.2 Cardiac Muscle and Cardiomyocytes |
|
|
577 | (2) |
|
17.3.3 Mechanical Performance of Muscular Tissue |
|
|
579 | (1) |
|
17.3.4 Stress--Strain Relationships of Muscular Tissues |
|
|
579 | (3) |
|
17.3.5 Reproducing J-Shaped Mechanical Properties in Synthetic Materials |
|
|
582 | (1) |
|
|
583 | (3) |
|
17.4.1 Cellular Organization and Histology of Nervous Tissue |
|
|
583 | (1) |
|
|
583 | (1) |
|
|
584 | (1) |
|
17.4.2 Anatomy of Peripheral Nerve Fibers |
|
|
585 | (1) |
|
|
586 | (23) |
|
|
587 | (1) |
|
Advanced Topic: Properties of Proteins in Mammalian Tissues |
|
|
587 | (13) |
|
Simple Questions in Class |
|
|
600 | (2) |
|
|
602 | (1) |
|
|
602 | (7) |
|
Chapter 18 Histology and Tissue Properties II: Connective Tissues |
|
|
609 | (26) |
|
|
609 | (1) |
|
18.1 Overview of Connective Tissues |
|
|
609 | (1) |
|
18.2 Types of Connective Tissue |
|
|
610 | (1) |
|
18.2.1 Connective Tissue Proper |
|
|
610 | (1) |
|
18.2.2 Connective Tissue with Specialized Properties |
|
|
610 | (1) |
|
18.2.3 Supporting Connective Tissue |
|
|
610 | (1) |
|
18.2.4 Embryonic Connective Tissue |
|
|
611 | (1) |
|
18.3 Connective Tissue Proper (Skin, Tendon, Ligament) |
|
|
611 | (6) |
|
18.3.1 Cells Present in Connective Tissue |
|
|
611 | (1) |
|
18.3.1.1 Fibroblasts and Fibrocytes |
|
|
612 | (1) |
|
|
612 | (1) |
|
|
613 | (1) |
|
|
613 | (1) |
|
|
613 | (1) |
|
|
613 | (1) |
|
18.3.2 Acellular Components of Connective Tissue |
|
|
614 | (1) |
|
18.3.2.1 Nonfibrous Gel-Like Substance |
|
|
614 | (1) |
|
18.3.2.2 Tissue Fluid (Interstitial Fluid) |
|
|
615 | (1) |
|
18.3.3 Structural Protein Fibers |
|
|
615 | (1) |
|
|
615 | (1) |
|
18.3.3.2 Reticular Fibers (Reticulin) |
|
|
616 | (1) |
|
18.3.3.3 Elastic Fiber System |
|
|
616 | (1) |
|
18.4 Mechanical Properties of Structural Proteins |
|
|
617 | (4) |
|
18.4.1 Elasticity of Biological Tissues |
|
|
617 | (1) |
|
18.4.2 Mechanical Properties of Collagen |
|
|
617 | (1) |
|
18.4.2.1 Elasticity of Collagen |
|
|
617 | (3) |
|
18.4.3 Mechanical Properties of Elastin |
|
|
620 | (1) |
|
18.4.4 Resilience of Proteins |
|
|
620 | (1) |
|
|
621 | (4) |
|
18.5.1 General Aspects of Anatomy and Function |
|
|
621 | (1) |
|
18.5.1.1 Hyaline Cartilage |
|
|
621 | (1) |
|
18.5.1.2 Elastic Cartilage |
|
|
622 | (1) |
|
|
623 | (1) |
|
18.5.2 Histology and Structural Aspects of Cartilage |
|
|
623 | (1) |
|
18.5.2.1 Extracellular Matrix of Cartilage |
|
|
623 | (1) |
|
|
623 | (1) |
|
18.5.2.3 Chondrocyte Growth in Cartilage |
|
|
623 | (1) |
|
18.5.3 Repair of Diseased or Damaged Cartilage |
|
|
623 | (1) |
|
18.5.3.1 Articular Cartilage Damage |
|
|
624 | (1) |
|
18.5.3.2 Current Clinical Treatments of Cartilage |
|
|
624 | (1) |
|
18.5.3.3 Total Joint Replacement |
|
|
625 | (1) |
|
18.5.3.4 Success of Cartilage Tissue Engineering |
|
|
625 | (1) |
|
|
625 | (4) |
|
|
625 | (1) |
|
18.6.1.1 Periosteum and Endosteum |
|
|
626 | (1) |
|
|
626 | (2) |
|
|
628 | (1) |
|
|
628 | (1) |
|
|
628 | (1) |
|
|
628 | (1) |
|
18.6.2.4 Osteoprogenitor Cells |
|
|
629 | (1) |
|
18.6.3 Mechanical Properties of Bone |
|
|
629 | (1) |
|
18.6.4 Bone Growth and Regeneration |
|
|
629 | (1) |
|
|
629 | (6) |
|
|
630 | (1) |
|
Simple Questions in Class |
|
|
630 | (2) |
|
|
632 | (1) |
|
|
632 | (3) |
|
Chapter 19 Immune System and Body Responses to Biomaterials |
|
|
635 | (20) |
|
|
635 | (1) |
|
|
635 | (7) |
|
19.1.1 Cells of the Immune System |
|
|
636 | (2) |
|
|
638 | (1) |
|
|
638 | (1) |
|
|
638 | (1) |
|
|
638 | (1) |
|
|
638 | (1) |
|
19.1.2.5 Eosinophils and Basopils |
|
|
638 | (1) |
|
|
639 | (1) |
|
19.13.1 B-Cells (from Bone Marrow) |
|
|
639 | (1) |
|
19.1.3.2 T-Cells (Produced in the Thymus) |
|
|
639 | (1) |
|
19.1.3.3 Natural Killer Cells |
|
|
640 | (2) |
|
19.2 Tissue Response to Injuries |
|
|
642 | (2) |
|
|
642 | (1) |
|
19.2.2 Remodeling Phase: Soft Tissue |
|
|
643 | (1) |
|
19.2.3 Remodeling Phase: Hard Tissue |
|
|
643 | (1) |
|
19.3 Body Response to Implants |
|
|
644 | (4) |
|
19.3.1 Local Tissue Responses |
|
|
645 | (1) |
|
|
645 | (1) |
|
|
645 | (1) |
|
19.3.1.3 Foreign Body Effects |
|
|
645 | (1) |
|
19.3.1.4 pH Change at Implantation Sites |
|
|
645 | (1) |
|
|
646 | (1) |
|
19.3.1.6 Local Carcinogenicity |
|
|
646 | (1) |
|
19.3.2 Local Tissue Responses to Different Materials |
|
|
646 | (1) |
|
19.3.3 Systemic Impact of Implants on the Body |
|
|
646 | (1) |
|
19.3.3.1 Metal and Trace Additive Allergy |
|
|
647 | (1) |
|
19.3.3.2 Carcinogenicity in Other Tissues |
|
|
647 | (1) |
|
19.3.4 Blood Compatibility |
|
|
647 | (1) |
|
|
647 | (1) |
|
19.3.4.2 Thromboresistance |
|
|
648 | (1) |
|
|
648 | (7) |
|
|
649 | (1) |
|
Simple Questions in Class |
|
|
649 | (1) |
|
|
650 | (1) |
|
|
651 | (4) |
|
PART III Evaluation and Regulation of Medical Devices |
|
|
|
Chapter 20 Evaluation of Biomaterials |
|
|
655 | (30) |
|
|
655 | (1) |
|
20.1 Overview of Biomaterials Evaluation |
|
|
655 | (1) |
|
20.1.1 Evaluation in the Context of Materials Science and Engineering |
|
|
655 | (1) |
|
20.1.2 Evaluation of Biomaterials in the Context of Biotechnology |
|
|
655 | (1) |
|
|
656 | (4) |
|
20.2.1 What Are Standards? |
|
|
656 | (2) |
|
20.2.2 Major International Standardization Organizations |
|
|
658 | (1) |
|
20.2.2.1 Standards of Biomaterials Evaluation |
|
|
659 | (1) |
|
20.2.3 Reference Materials (Controls) |
|
|
659 | (1) |
|
20.2.3.1 Blood--Material Interaction Studies |
|
|
659 | (1) |
|
20.2.4 Sterilization Practices |
|
|
660 | (1) |
|
20.2.4.1 Choice of Sterilization Methods |
|
|
660 | (1) |
|
20.3 Toxicological Evaluation |
|
|
660 | (5) |
|
20.3.1 Scheduling of Testing |
|
|
661 | (1) |
|
20.3.2 Causes of Toxicity Problems |
|
|
661 | (1) |
|
20.3.2.1 Leaching from Polymers |
|
|
662 | (1) |
|
20.3.2.2 Sterilization by-products |
|
|
662 | (1) |
|
20.3.2.3 Drug--Plastic Interactions |
|
|
662 | (1) |
|
20.3.2.4 Biodegradation and/or Biotransformation of Materials |
|
|
662 | (1) |
|
20.3.2.5 Physical Contact |
|
|
663 | (1) |
|
20.3.3 Toxicity Test Methods |
|
|
663 | (1) |
|
|
663 | (1) |
|
|
663 | (1) |
|
20.3.3.3 Tissue Reactivity after Irritation or Intracutaneous Injection |
|
|
663 | (1) |
|
20.3.3.4 Acute Systemic Toxicity |
|
|
664 | (1) |
|
20.3.3.5 Subchronic Toxicity |
|
|
664 | (1) |
|
|
664 | (1) |
|
|
664 | (1) |
|
20.3.3.8 Hemocompatibility |
|
|
664 | (1) |
|
20.3.3.9 Chronic Toxicity |
|
|
664 | (1) |
|
20.3.3.10 Carcinogenicity/Reproductive Toxicity |
|
|
664 | (1) |
|
20.4 Cytotoxicity Testing |
|
|
665 | (2) |
|
20.4.1 Cytotoxicity Test Methods |
|
|
665 | (1) |
|
20.4.1.1 Cytotoxicity Method I: Extract (Elution) |
|
|
666 | (1) |
|
20.4.1.2 Cytotoxicity Method II: Contact |
|
|
666 | (1) |
|
20.4.1.3 Comparison of Extract and Contact |
|
|
666 | (1) |
|
20.5 Evaluation in Animals |
|
|
667 | (2) |
|
|
667 | (1) |
|
20.5.2 Selection of Animal Models |
|
|
667 | (1) |
|
|
668 | (1) |
|
|
668 | (1) |
|
|
668 | (1) |
|
|
668 | (1) |
|
|
668 | (1) |
|
20.5.2.6 Dental Applications |
|
|
668 | (1) |
|
|
668 | (1) |
|
20.5.2.8 Respiratory System |
|
|
668 | (1) |
|
20.5.2.9 Urogenital Tract |
|
|
669 | (1) |
|
|
669 | (1) |
|
|
669 | (16) |
|
|
669 | (1) |
|
Case Study: Evaluation of Heart Patch in Rats |
|
|
669 | (10) |
|
Simple Questions in Class |
|
|
679 | (1) |
|
|
680 | (1) |
|
|
681 | (4) |
|
Chapter 21 Regulation of Medical Devices |
|
|
685 | (8) |
|
|
685 | (1) |
|
21.1 Regulations versus Standards |
|
|
685 | (1) |
|
|
686 | (2) |
|
21.2.1 Definition of Medical Devices |
|
|
686 | (1) |
|
21.2.2 Biomaterials in the Legal Context |
|
|
687 | (1) |
|
21.2.3 Classification of Medical Devices in the Legal Field |
|
|
687 | (1) |
|
21.2.3.1 Classification in Canada and EU |
|
|
687 | (1) |
|
21.2.3.2 Classification in the United States |
|
|
687 | (1) |
|
21.2.3.3 Classification of TGA |
|
|
687 | (1) |
|
|
688 | (1) |
|
|
688 | (2) |
|
21.4.1 Phase I Trials: Is the Treatment Safe? |
|
|
688 | (1) |
|
21.4.2 Phase II Trials: Is the Treatment Effective? |
|
|
688 | (1) |
|
21.4.3 Phase III Trials: How Does the Treatment Compare? |
|
|
689 | (1) |
|
21.4.4 Phase IV Trials: Postmarket Surveillance |
|
|
689 | (1) |
|
21.5 Development of Medical Devices and Possible Career Opportunities |
|
|
690 | (1) |
|
|
691 | (2) |
|
|
691 | (1) |
|
Simple Questions in Class |
|
|
691 | (1) |
|
|
692 | (1) |
|
|
692 | (1) |
Index |
|
693 | |